Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEARL III: Ulipristal Acetate in Uterine Fibroids
NCT01156857Phase 3Completed
- Sponsor
- PregLem
- Start
- Jul 2010
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 3, randomised, double-blind trial in Uterine Fibroids (UF) comparing PGL4001 then Placebo with PGL4001 then Progestin (2 arms). Primary endpoints: Proportion of subjects in amenorrhea at 3 months, Change in myoma size at 3 months and 3 more. Started Jul 2010; status: completed.
02
Drugs
ulipristal
03
Conditions
Uterine Fibroids (UF)
Beyond the preview
Go deeper on NCT01156857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01156857.